The DOI matches its Crossref record; 46 of the 46 references it cites were found in a registry or an index.
RNA-Guided Human Genome Engineering via Cas9
Open accessAbstract
Genome Editing: Clustered regularly interspaced short palindromic repeats (CRISPR) function as part of an adaptive immune system in a range of prokaryotes: Invading phage and plasmid DNA is targeted for cleavage by complementary CRISPR RNAs (crRNAs) bound to a CRISPR-associated endonuclease (see the Perspective by van der Oost ). Cong et al. (p. 819 , published online 3 January) and Mali et al. (p. 823 , published online 3 January) adapted this defense system to function as a genome editing tool in eukaryotic cells.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Upon target recognition, the DNA strands are opened in an R-loop and individually cleaved, which results in a double-strand break (DSB)22,23”
From One-step generation of tumor models by base editor multiplexing in adult stem cell-derived organoids (2023) · cites this paper as [23]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The technique also allows DNA sequence changes in pluripotent embryonic stem cells (4) that can then be cultured to produce specific tissues, such as cardiomyocytes or neurons (5).”
From A prudent path forward for genomic engineering and germline gene modification (2015) · cites this paper as [4]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In January 2013, almost simultaneously, five research articles authored by different research teams appeared, all reporting that they had achieved the goal.”
From CRISPR–Cas9: A History of Its Discovery and Ethical Considerations of Its Use in Genome Editing (2022) · cites this paper as [34]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Mali et al. created a novel version of the genome-editing tool applicable to mammalian cells, termed the CRISPR/Cas9 system, which is based on modifications of the Streptococcus pyogenes type II CRISPR system in crRNA fused to trans-encoded tracrRNA 13 .”
From Harnessing the CRISPR/Cas9 system to disrupt latent HIV-1 provirus (2013) · cites this paper as [13]
The cited source says what the claim attributes to it.
In the citing paper
“The pigs were engineered to carry 69 genomic edits, using the clustered regularly interspaced short palindromic repeats (CRISPR) and CRISPR-associated protein 9 (Cas9)-mediated nonhomologous end joining and homology-directed repair30,31, and recombinase-mediated cassette exchange32 (Fig. 2a, Extended Data Fig. 1a and Supplementary Table 2).”
From Design and testing of a humanized porcine donor for xenotransplantation (2023) · cites this paper as [31]
In the citing paper
“When a double-stranded break is introduced into genomic DNA, cells can repair the break by using a DNA molecule with high sequence similarity as a template. If an artificial template is provided while the DNA break is introduced, this pathway provides a mean to incorporate desired DNA sequences into the genome34,35”
From CRISPR-based functional genomics for neurological disease (2020) · cites this paper as [35]
In the citing paper
“The discovery, made less than 10 years ago, that a simple two-component system of a Cas protein (Streptococcus pyogenes Cas9) bound to a single guide RNA (sgRNA) can function as a programmable nuclease33 that can be deployed to cleave specific sequences in mammalian genomes34,35 has been transformative for biomedical research and the development of gene therapies.”
From CRISPR-based functional genomics for neurological disease (2020) · cites this paper as [35]
In the citing paper
“Recently, the CRISPR/Cas system has been successfully applied to human cells19,20,21,22 and several model organisms for genome editing.23,24,25,26”
From The CRISPR/Cas9 system facilitates clearance of the intrahepatic HBV templates in vivo (2014) · cites this paper as [19]
In the citing paper
“By bioinformatic screening and efficiency/off-target prediction (14, 15), we identified four gRNA targets (protospacers; LTRs A-D) that avoid conserved transcription factor binding sites, minimizing the likelihood of altering host gene expression”
From RNA-directed gene editing specifically eradicates latent and prevents new HIV-1 infection (2014) · cites this paper as [15]
In the citing paper
“Compared with well-known, site-specific genome editing technologies, such as ZFNs and TALENs, the new CRISPR-Cas approach is more convenient and efficient [10], [12].”
From High-efficiency targeted editing of large viral genomes by RNA-guided nucleases (2014) · cites this paper as [10]
In the citing paper
“Clustered regularly interspaced short palindromic repeat (CRISPR)/Cas9 is a naturally occurring bacterial immune system that uses a novel nuclease system to protect bacteria from phage infection (6-9), and it has recently been harnessed for a variety of genome-engineering applications (10)(11)(12)(13)(14)(15)(16)(17).”
From RNA-guided endonuclease provides a therapeutic strategy to cure latent herpesviridae infection (2014) · cites this paper as [13]
In the citing paper
“Moreover, no significant cytotoxicity was observed [87,88].”
From Newer Gene Editing Technologies toward HIV Gene Therapy (2013) · cites this paper as [88]
In the citing paper
“although Cas9 protein naturally induces double stranded DNA breaks by cutting each strand with two separate motifs, a mutation within one of the enzymatic motifs of Cas9 converted it into a valuable nickase with the capability to induce homologous recombination”
From Newer Gene Editing Technologies toward HIV Gene Therapy (2013) · cites this paper as [88]
In the citing paper
“and the mutant is much safer to use with less off-target effects [88].”
From Newer Gene Editing Technologies toward HIV Gene Therapy (2013) · cites this paper as [88]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
BEDTools: a flexible suite of utilities for comparing genomic features
Quinlan, A. R., & Hall, I. M. (2010) · Bioinformatics · doi:10.1093/bioinformatics/btq033 · Cited by 27,437
Ultrafast and memory-efficient alignment of short DNA sequences to the human genome.
Langmead, B., Trapnell, C., Pop, M., & Salzberg, S. L. (2009) · Genome Biology · doi:10.1186/gb-2009-10-3-r25 · Cited by 21,849
A Programmable Dual-RNA–Guided DNA Endonuclease in Adaptive Bacterial Immunity
Jinek, M., Chylinski, K., Fonfara, I., Hauer, M., Doudna, J. A., & Charpentier, E. (2012) · Science · doi:10.1126/science.1225829 · Cited by 17,116
Multiplex Genome Engineering Using CRISPR/Cas Systems
Cong, L., Ran, F. A., Cox, D., Lin, S., Barretto, R., Habib, N., Hsu, P. D., Wu, X., Jiang, W., Marraffini, L. A., et al. (2013) · Science · doi:10.1126/science.1231143 · Cited by 15,339
The Human Genome Browser at UCSC
Kent, W. J., Sugnet, C. W., Furey, T. S., Roskin, K. M., Pringle, T. H., Zahler, A. M., & Haussler, A. D. (2002) · Genome Research · doi:10.1101/gr.229102 · Cited by 10,400
Lorenz, R., Bernhart, S. H., Höner zu Siederdissen, C., Tafer, H., Flamm, C., Stadler, P. F., & Hofacker, I. L. (2011) · Algorithms for Molecular Biology · doi:10.1186/1748-7188-6-26 · Cited by 5,098
A System for Stable Expression of Short Interfering RNAs in Mammalian Cells
Brummelkamp, T. R., Bernards, R., & Agami, R. (2002) · Science · doi:10.1126/science.1068999 · Cited by 4,295
Mathews, D. H., Sabina, J., Zuker, M., & Turner, D. H. (1999) · Journal of Molecular Biology · doi:10.1006/jmbi.1999.2700 · Cited by 3,795
Gasiunas, G., Barrangou, R., Horvath, P., & Siksnys, V. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1208507109 · Cited by 2,769
The accessible chromatin landscape of the human genome
Thurman, R. E., Rynes, E., Humbert, R., Vierstra, J., Maurano, M. T., Haugen, E., Sheffield, N. C., Stergachis, A. B., Wang, H., Vernot, B., et al. (2012) · Nature · doi:10.1038/nature11232 · Cited by 2,679
Flagged first, then by citations
Cited by
Sorted by citations
Items 901–1,000 of 1,104
Rational designs of in vivo CRISPR-Cas delivery systems
Xu, C., Chen, G., Luo, Y., Zhang, Y., Zhao, G., Lu, Z.-D., Czarna, A., Gu, Z., & Wang, J. (2019) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2019.11.005 · Cited by 187
CRISPR/dCas9 Tools: Epigenetic Mechanism and Application in Gene Transcriptional Regulation
Cai, R., Lv, R., Shi, X., Yang, G., & Jin, J. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241914865 · Cited by 189
In vivo genome editing improves motor function and extends survival in a mouse model of ALS
Gaj, T., Ojala, D. S., Ekman, F. K., Byrne, L. C., Limsirichai, P., & Schaffer, D. V. (2017) · Science Advances · doi:10.1126/sciadv.aar3952 · Cited by 185
Off-target predictions in CRISPR-Cas9 gene editing using deep learning
Lin, J., & Wong, K.-C. (2018) · Bioinformatics · doi:10.1093/bioinformatics/bty554 · Cited by 185
Biallelic genome modification in F 0 Xenopus tropicalis embryos using the CRISPR/Cas system
Blitz, I. L., Biesinger, J., Xie, X. S., & Cho, K. W. Y. (2013) · genesis · doi:10.1002/dvg.22719 · Cited by 185
Implementation of the CRISPR-Cas9 system in fission yeast
Jacobs, J. Z., Ciccaglione, K. M., Tournier, V., & Zaratiegui, M. (2014) · Nature Communications · doi:10.1038/ncomms6344 · Cited by 185
Synthetic CRISPR RNA-Cas9–guided genome editing in human cells
Rahdar, M., McMahon, M. A., Prakash, T. P., Swayze, E. E., Bennett, C. F., & Cleveland, D. W. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1520883112 · Cited by 184
A CRISPR toolbox to study virus–host interactions
Puschnik, A. S., Majzoub, K., Ooi, Y. S., & Carette, J. E. (2017) · Nature Reviews Microbiology · doi:10.1038/nrmicro.2017.29 · Cited by 185
CRISPR–Cas: a tool for cancer research and therapeutics
Yin, H., Xue, W., & Anderson, D. G. (2019) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-019-0166-8 · Cited by 185
Evolution of adaptive immunity from transposable elements combined with innate immune systems
Koonin, E. V., & Krupovìč, M. (2014) · Nature Reviews Genetics · doi:10.1038/nrg3859 · Cited by 183
Unravelling cellular relationships during development and regeneration using genetic lineage tracing
Baron, C. S., & van Oudenaarden, A. (2019) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-019-0186-3 · Cited by 183
Drug delivery systems for CRISPR-based genome editors
Madigan, V. J., Zhang, F., & Dahlman, J. E. (2023) · Nature Reviews Drug Discovery · doi:10.1038/s41573-023-00762-x · Cited by 193
Davidson, L., Muniz, L., & West, S. (2014) · Genes & Development · doi:10.1101/gad.231274.113 · Cited by 183
New pharmacological approaches for cystic fibrosis: Promises, progress, pitfalls
Bell, S. C., Boeck, K. D., & Amaral, M. D. (2014) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2014.06.005 · Cited by 182
The structural biology of CRISPR-Cas systems
Jiang, F., & Doudna, J. A. (2015) · Current Opinion in Structural Biology · doi:10.1016/j.sbi.2015.02.002 · Cited by 182
CRISPR-Cas: an efficient tool for genome engineering of virulent bacteriophages
Martel, B., & Moineau, S. (2014) · Nucleic Acids Research · doi:10.1093/nar/gku628 · Cited by 182
Parallel shRNA and CRISPR-Cas9 screens enable antiviral drug target identification
Deans, R. M., Morgens, D. W., Ökesli, A., Pillay, S., Horlbeck, M. A., Kampmann, M., Gilbert, L. A., Li, A., Mateo, R., Smith, M. A., et al. (2016) · Nature Chemical Biology · doi:10.1038/nchembio.2050 · Cited by 182
Is It Time for Synthetic Biodiversity Conservation?
Piaggio, A. J., Segelbacher, G., Seddon, P. J., Alphey, L., Bennett, E. L., Carlson, R. H., Friedman, R. M., Kanavy, D., Phelan, R. M., Redford, K. H., et al. (2016) · Trends in Ecology & Evolution · doi:10.1016/j.tree.2016.10.016 · Cited by 182
Wang, W., Simmonds, J., Pan, Q., Davidson, D., He, F., Battal, A., Akhunova, A. R., Trick, H. N., Uauy, C., & Akhunov, E. (2018) · Theoretical and Applied Genetics · doi:10.1007/s00122-018-3166-7 · Cited by 182
Critical roles of long noncoding RNAs in Drosophila spermatogenesisPreprint
Wen, K., Yang, L., Xiong, T., Di, C., Ma, D., Wu, M., Xue, Z., Zhang, X., Li, L., Zhang, W., et al. (2016) · Genome Research · doi:10.1101/gr.199547.115 · Cited by 182
Self-citationZebrafish Genome Engineering Using the CRISPR–Cas9 System
Li, M., Zhao, L., Page-McCaw, P., & Chen, W. (2016) · Trends in Genetics · doi:10.1016/j.tig.2016.10.005 · Cited by 181
Marker-free coselection for CRISPR-driven genome editing in human cells
Agudelo, D., Duringer, A., Bozoyan, L., Huard, C., Carter, S., Loehr, J., Synodinou, D., Drouin, M., Salsman, J., Dellaire, G., et al. (2017) · Nature Methods · doi:10.1038/nmeth.4265 · Cited by 183
RNA-guided transcriptional silencing in vivo with S. aureus CRISPR-Cas9 repressors
Thakore, P. I., Kwon, J. B., Nelson, C. E., Rouse, D. C., Gemberling, M. P., Oliver, M. L., & Gersbach, C. A. (2018) · Nature Communications · doi:10.1038/s41467-018-04048-4 · Cited by 181
Challenges and opportunities for hydrogen production from microalgae
Oey, M., Sawyer, A. L., Ross, I. L., & Hankamer, B. (2016) · Plant Biotechnology Journal · doi:10.1111/pbi.12516 · Cited by 180
Lo, T., Pickle, C. S., Lin, S., Ralston, E. J., Gurling, M., Schartner, C., Bian, Q., Doudna, J. A., & Meyer, B. J. (2013) · Genetics · doi:10.1534/genetics.113.155382 · Cited by 180
Efficient and Allele-Specific Genome Editing of Disease Loci in Human iPSCs
Smith, C. J., Abalde-Atristain, L., He, C., Brodsky, B. R., Braunstein, E. M., Chaudhari, P., Jang, Y.-Y., Cheng, L., & Ye, Z. (2014) · Molecular Therapy · doi:10.1038/mt.2014.226 · Cited by 180
Targeted gene knockout in chickens mediated by TALENs
Park, T. S., Lee, H. J., Kim, K. H., Kim, J., & Han, J. Y. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1410555111 · Cited by 180
Harrod, A., Fulton, J., Nguyen, V. T. M., Periyasamy, M., Ramos-Garcia, L., Lai, C.-F., Metodieva, G., de Giorgio, A., WILLIAMS, R., Santos, D. B., et al. (2016) · Oncogene · doi:10.1038/onc.2016.382 · Cited by 180
Li, M., Bui, M., Yang, T., Bowman, C. S., White, B. J., & Akbari, O. S. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1711538114 · Cited by 180
Liu, Z., Chen, S., Jin, X., Wang, Q., Yang, K., Li, C., Xiao, Q., Hou, P., Liu, S., Wu, S., et al. (2017) · Cell & Bioscience · doi:10.1186/s13578-017-0174-2 · Cited by 131
CRISPR/Cas9-based genome editing of the filamentous fungi: the state of the art
Shi, T., Liu, G., Ji, R.-Y., Shi, K., Song, P., Ren, L., Huang, H., & Ji, X. (2017) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-017-8497-9 · Cited by 180
Guan, Y., Ma, Y., Li, Q., Sun, Z., Ma, L., Wu, L., Wang, L., Zeng, L., Shao, Y., Chen, Y., et al. (2016) · EMBO Molecular Medicine · doi:10.15252/emmm.201506039 · Cited by 179
Rapid and Efficient One-Step Metabolic Pathway Integration in E. coli
Bassalo, M. C., Garst, A. D., Halweg‐Edwards, A. L., Grau, W. C., Domaille, D. W., Mutalik, V. K., Arkin, A. P., & Gill, R. T. (2016) · ACS Synthetic Biology · doi:10.1021/acssynbio.5b00187 · Cited by 179
Wang, Y., Zhang, Z.-T., Seo, S.-O., Patrick, L., Lu, T., Jin, Y., & Blaschek, H. P. (2016) · ACS Synthetic Biology · doi:10.1021/acssynbio.6b00060 · Cited by 179
Deciphering, Communicating, and Engineering the CRISPR PAM
Leenay, R. T., & Beisel, C. L. (2016) · Journal of Molecular Biology · doi:10.1016/j.jmb.2016.11.024 · Cited by 180
Savić, N., Ringnalda, F. C. A. S., Lindsay, H. A., Berk, C., Bargsten, K., Li, Y., Neri, D., Robinson, M. D., Ciaudo, C., Hall, J., et al. (2018) · eLife · doi:10.7554/elife.33761 · Cited by 179
Genome Editing—Principles and Applications for Functional Genomics Research and Crop Improvement
Zhang, H., Zhang, J., Lang, Z., Botella, J. R., & Zhu, J. (2017) · Critical Reviews in Plant Sciences · doi:10.1080/07352689.2017.1402989 · Cited by 179
Bak, R. O., Gomez‐Ospina, N., & Porteus, M. H. (2018) · Trends in Genetics · doi:10.1016/j.tig.2018.05.004 · Cited by 181
Park, C.-Y., Halevy, T., Lee, D. R., Sung, J. J., Lee, J. S., Yanuka, O., Benvenisty, N., & Kim, D.-W. (2015) · Cell Reports · doi:10.1016/j.celrep.2015.08.084 · Cited by 178
CRISPR/Cas9 and TALEN-mediated knock-in approaches in zebrafish
Auer, T. O., & Bene, F. D. (2014) · Methods · doi:10.1016/j.ymeth.2014.03.027 · Cited by 178
Homing endonucleases from mobile group I introns: discovery to genome engineering
Stoddard, B. L. (2014) · Mobile DNA · doi:10.1186/1759-8753-5-7 · Cited by 178
Su, Z., Kuscu, C., Malik, A. A., Shibata, E., & Dutta, A. (2019) · Journal of Biological Chemistry · doi:10.1074/jbc.ra119.009272 · Cited by 181
Woodruff, G., Young, J. E., Martinez, F. J., Buen, F., Gore, A., Kinaga, J., Li, Z., Yuan, S. H., Zhang, K., & Goldstein, L. S. B. (2013) · Cell Reports · doi:10.1016/j.celrep.2013.10.018 · Cited by 177
megaTALs: a rare-cleaving nuclease architecture for therapeutic genome engineering
Boissel, S., Jarjour, J., Astrakhan, A., Adey, A., Gouble, A., Duchateau, P. N., Shendure, J., Stoddard, B. L., Certo, M. T., Baker, D. A., et al. (2013) · Nucleic Acids Research · doi:10.1093/nar/gkt1224 · Cited by 177
3D Culture Supports Long-Term Expansion of Mouse and Human Nephrogenic Progenitors
Li, Z., Araoka, T., Wu, J., Liao, H.-K., Li, M., Lazo-Rodríguez, M., Zhou, B., Sui, Y., Wu, M.-Z., Tamura, I., et al. (2016) · Cell stem cell · doi:10.1016/j.stem.2016.07.016 · Cited by 177
DNA-based memory devices for recording cellular events
Sheth, R. U., & Wang, H. H. (2018) · Nature Reviews Genetics · doi:10.1038/s41576-018-0052-8 · Cited by 179
Genome editing for plant disease resistance: applications and perspectives
Yin, K., & Qiu, J. (2019) · Philosophical Transactions of the Royal Society B Biological Sciences · doi:10.1098/rstb.2018.0322 · Cited by 177
A catalogue of biochemically diverse CRISPR-Cas9 orthologs
Gasiūnas, G., Young, J. K., Karvelis, T., Kazlauskas, D., Urbaitis, T., Jasnauskaitė, M., Grusyte, M. M., Paulraj, S., Wang, P.-H., Hou, Z., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-19344-1 · Cited by 181
CARF and WYL domains: ligand-binding regulators of prokaryotic defense systems
Makarova, K. S., Anantharaman, V., Grishin, N. V., Koonin, E. V., & Aravind, L. (2014) · Frontiers in Genetics · doi:10.3389/fgene.2014.00102 · Cited by 176
Generation of Genomic Deletions in Mammalian Cell Lines via CRISPR/Cas9
Bauer, D. E., Canver, M. C., & Orkin, S. H. (2014) · Journal of Visualized Experiments · doi:10.3791/52118 · Cited by 176
Dombrovsky, A., Tran‐Nguyen, L. T. T., & Jones, R. A. C. (2017) · Annual Review of Phytopathology · doi:10.1146/annurev-phyto-080516-035349 · Cited by 176
Generation of thermosensitive male-sterile maize by targeted knockout of the ZmTMS5 gene
Li, J., Zhang, H., Si, X., Tian, Y., Chen, K., Liu, J., Chen, H., & Gao, C. (2017) · Journal of genetics and genomics/Journal of Genetics and Genomics · doi:10.1016/j.jgg.2017.02.002 · Cited by 176
Synthetic biology and metabolic engineering of actinomycetes for natural product discovery
Palazzotto, E., Tong, Y., Lee, S. Y., & Weber, T. (2019) · Biotechnology Advances · doi:10.1016/j.biotechadv.2019.03.005 · Cited by 176
Perspectives on the Application of Genome-Editing Technologies in Crop Breeding
Hua, K., Zhang, J., Botella, J. R., Ma, C., Kong, F., Liu, B., & Zhu, J. (2019) · Molecular Plant · doi:10.1016/j.molp.2019.06.009 · Cited by 177
The solute carrier SLC35F2 enables YM155-mediated DNA damage toxicity
Winter, G. E., Radic, B., Mayor-Ruiz, C., Blomen, V. A., Trefzer, C., Kandasamy, R. K., Huber, K. V. M., Gridling, M., Chen, D., Klampfl, T., et al. (2014) · Nature Chemical Biology · doi:10.1038/nchembio.1590 · Cited by 175
Horii, T., Arai, Y., Yamazaki, M., Morita, S., Kimura, M., Itoh, M., Abe, Y., & Hatada, I. (2014) · Scientific Reports · doi:10.1038/srep04513 · Cited by 175
Efficient CRISPR-mediated gene targeting and transgene replacement in the beetleTribolium castaneum
Gilles, A. F., Schinko, J. B., & Averof, M. (2015) · Development · doi:10.1242/dev.125054 · Cited by 175
Rapid and tunable method to temporally control gene editing based on conditional Cas9 stabilization
Şentürk, Ş., Shirole, N. H., Nowak, D. G., Corbo, V., Pal, D., Vaughan, A., Tuveson, D. A., Trotman, L. C., Kinney, J. B., & Sordella, R. (2017) · Nature Communications · doi:10.1038/ncomms14370 · Cited by 175
Recent progress in mass spectrometry proteomics for biomedical research
Li, X., Wang, W., & Chen, J. (2017) · Science China Life Sciences · doi:10.1007/s11427-017-9175-2 · Cited by 176
Efficient CRISPR/Cas9-based genome editing in carrot cells
Klimek‐Chodacka, M., Oleszkiewicz, T., Lowder, L. G., Qi, Y., & Barański, R. (2018) · Plant Cell Reports · doi:10.1007/s00299-018-2252-2 · Cited by 177
Zafar, K., Khan, M. Z., Amin, I. U., Mukhtar, Z., Yasmin, S., Arif, M. F., Ejaz, K., & Mansoor, S. (2020) · Frontiers in Plant Science · doi:10.3389/fpls.2020.00575 · Cited by 175
Dual-AAV delivering split prime editor system for in vivo genome editing
Zhi, S., Chen, Y., Wu, G., Wen, J., Wu, J., Liu, Q., Li, Y., Kang, R., Hu, S., Wang, J., et al. (2022) · Molecular Therapy · doi:10.1016/j.ymthe.2021.07.011 · Cited by 174
Stem Cells Marked by the R-Spondin Receptor LGR5
Koo, B., & Clevers, H. C. (2014) · Gastroenterology · doi:10.1053/j.gastro.2014.05.007 · Cited by 174
Zhang, Y., Yin, C., Zhang, T., Li, F., Yang, W., Kaminski, R., Fagan, P. R., Putatunda, R., Young, W., Khalili, K., et al. (2015) · Scientific Reports · doi:10.1038/srep16277 · Cited by 174
Protze, S. I., Lee, J. H., & Keller, G. M. (2019) · Cell Stem Cell · doi:10.1016/j.stem.2019.07.010 · Cited by 162
Prykhozhij, S. V., Rajan, V., Gaston, D., & Berman, J. N. (2015) · PLoS ONE · doi:10.1371/journal.pone.0119372 · Cited by 173
A modular toolbox for gRNA–Cas9 genome engineering in plants based on the GoldenBraid standard
Vázquez‐Vilar, M., Bernabé‐Orts, J. M., Fernández‐del‐Carmen, A., Ziarsolo, P., Blanca, J., Granell, A., & Orzáez, D. (2016) · Plant Methods · doi:10.1186/s13007-016-0101-2 · Cited by 173
Wang, J., Zhang, H., Wang, H., Zhao, S., Zuo, Y., Yang, Y., & Wu, Y. (2016) · Insect Biochemistry and Molecular Biology · doi:10.1016/j.ibmb.2016.06.008 · Cited by 173
Current CRISPR gene drive systems are likely to be highly invasive in wild populations
Noble, C., Adlam, B., Church, G. M., Esvelt, K. M., & Nowak, M. A. (2018) · eLife · doi:10.7554/elife.33423 · Cited by 173
Self-citationEzh2-dCas9 and KRAB-dCas9 enable engineering of epigenetic memory in a context-dependent manner
O’Geen, H., Bates, S. L., Carter, S., Nisson, K., Halmai, J. A. N. M., Fink, K. D., Rhie, S. K., Farnham, P., & Segal, D. J. (2019) · Epigenetics & Chromatin · doi:10.1186/s13072-019-0275-8 · Cited by 173
Feng, J., Qian, Y., Zhou, Z., Sarah, E., Vivas, E. I., Lan, F., Hamilton, J. J., Rey, F. E., Anantharaman, K., & Venturelli, O. S. (2022) · Cell Host & Microbe · doi:10.1016/j.chom.2021.12.006 · Cited by 173
Sato, K., Oiwa, R., Kumita, W., Henry, R., Sakuma, T., Ito, R., Nozu, R., Inoue, T., Katano, I., Sato, K., et al. (2016) · Cell Stem Cell · doi:10.1016/j.stem.2016.06.003 · Cited by 159
Peterson, B. A., Haak, D. C., Nishimura, M. T., Teixeira, P. J. P. L., James, S. R., Dangl, J. L., & Nimchuk, Z. L. (2016) · PLOS ONE · doi:10.1371/journal.pone.0162169 · Cited by 172
Dogma Derailed: The Many Influences of RNA on the Genome
Sabin, L. R., Delàs, M. J., & Hannon, G. J. (2013) · Molecular Cell · doi:10.1016/j.molcel.2013.02.010 · Cited by 172
Advances in CRISPR-Cas9 genome engineering: lessons learned from RNA interference
Barrangou, R., Birmingham, A., Wiemann, S., Beijersbergen, R. L., Hornung, V., & Smith, A. V. B. (2015) · Nucleic Acids Research · doi:10.1093/nar/gkv226 · Cited by 173
Targeted DNA degradation using a CRISPR device stably carried in the host genome
Caliando, B. J., & Voigt, C. A. (2015) · Nature Communications · doi:10.1038/ncomms7989 · Cited by 172
Li, Q., Chen, J., Minton, N. P., Zhang, Y., Wen, Z., Liu, J., Yang, H., Zeng, Z., Ren, X., Yang, J., et al. (2016) · Biotechnology Journal · doi:10.1002/biot.201600053 · Cited by 172
Exploring the potential of genome editing CRISPR-Cas9 technology
Singh, V., Braddick, D., & Dhar, P. K. (2016) · Gene · doi:10.1016/j.gene.2016.11.008 · Cited by 172
Highly Effective and Low-Cost MicroRNA Detection with CRISPR-Cas9
Qiu, X., Zhu, L., Zhu, C., Ma, J., Hou, T., Wu, X., Xie, S., Lu, M., Tan, D., Zhang, D., et al. (2018) · ACS Synthetic Biology · doi:10.1021/acssynbio.7b00446 · Cited by 172
Evaluating and enhancing target specificity of gene-editing nucleases and deaminases
Kim, D., Luk, K., Wolfe, S. A., & Kim, J.-S. (2019) · Annual Review of Biochemistry · doi:10.1146/annurev-biochem-013118-111730 · Cited by 171
Hyun, Y., Kim, J., Cho, S. W., Choi, Y., Kim, J., & Coupland, G. (2014) · Planta · doi:10.1007/s00425-014-2180-5 · Cited by 171
TALEN or Cas9 – Rapid, Efficient and Specific Choices for Genome Modifications
Wei, C., Liu, J., Yu, Z., Zhang, B., Gao, G., & Jiao, R. (2013) · Journal of genetics and genomics/Journal of Genetics and Genomics · doi:10.1016/j.jgg.2013.03.013 · Cited by 171
Songstad, D. D., Petolino, J. F., Voytas, D. F., & Reichert, N. A. (2017) · Critical Reviews in Plant Sciences · doi:10.1080/07352689.2017.1281663 · Cited by 171
Therapeutic approaches targeting Apolipoprotein E function in Alzheimer’s disease
Williams, T., Borchelt, D., & Chakrabarty, P. (2020) · Molecular Neurodegeneration · doi:10.1186/s13024-020-0358-9 · Cited by 172
Efficient RNA/Cas9-mediated genome editing in Xenopus tropicalis
Guo, X., Zhang, T., Hu, Z. M., Zhang, Y., Shi, Z., Wang, Q., Cui, Y., Wang, F., Zhao, H., & Chen, Y. (2014) · Development · doi:10.1242/dev.099853 · Cited by 170
CRISPR-Cas9D10A nickase-based genotypic and phenotypic screening to enhance genome editing
Chiang, T.-W. W., le Sage, C., Larrieu, D., Demir, M., & Jackson, S. P. (2016) · Scientific Reports · doi:10.1038/srep24356 · Cited by 171
DNA-guided genome editing using the Natronobacterium gregoryi Argonaute
Gao, F., Shen, X. Z., Jiang, F., Wu, Y., & Han, C. (2016) · Nature Biotechnology · doi:10.1038/nbt.3547 · Cited by 170
RetractedYamada, M., Watanabe, Y., Gootenberg, J. S., Hirano, H., Ran, F. A., Nakane, T., Ishitani, R., Zhang, F., Nishimasu, H., & Nureki, O. (2017) · Molecular Cell · doi:10.1016/j.molcel.2017.02.007 · Cited by 170
Liu, P., Chen, M., Liu, Y., Qi, L. S., & Ding, S. (2018) · Cell stem cell · doi:10.1016/j.stem.2017.12.001 · Cited by 170
Engineered dCas9 with reduced toxicity in bacteria: implications for genetic circuit design
Zhang, S., & Voigt, C. A. (2018) · Nucleic Acids Research · doi:10.1093/nar/gky884 · Cited by 171
Ahmad, S., Wei, X., Sheng, Z., Hu, P., & Tang, S. (2019) · Briefings in Functional Genomics · doi:10.1093/bfgp/elz041 · Cited by 169
R-loop formation and conformational activation mechanisms of Cas9
Pačesa, M., Loeff, L., Querques, I., Muckenfuss, L. M., Sawicka, M., & Jínek, M. (2022) · Nature · doi:10.1038/s41586-022-05114-0 · Cited by 176
Zhang, G.-C., Kong, I. I., Kim, H., Liu, J., Cate, J. H. D., & Jin, Y. (2014) · Applied and Environmental Microbiology · doi:10.1128/aem.02310-14 · Cited by 169
Identification of LZTFL1 as a candidate effector gene at a COVID-19 risk locus
Downes, D. J., Cross, A. R., Peng, H., Roberts, N. A., Schweßinger, R., Cutler, A. J., Munis, A. M., Brown, J. M., Mielczarek, O., de Andrea, C. E., et al. (2021) · Nature Genetics · doi:10.1038/s41588-021-00955-3 · Cited by 174
Passenger Mutations Confound Interpretation of All Genetically Modified Congenic Mice
Berghe, T. V., Hulpiau, P., Martens, L., Vandenbroucke, R. E., Wonterghem, E. V., Perry, S. W., Bruggeman, I., Divert, T., Choi, S. M., Vuylsteke, M., et al. (2015) · Immunity · doi:10.1016/j.immuni.2015.06.011 · Cited by 168
Latella, M. C., Salvo, M. T. D., Cocchiarella, F., Benati, D., Grisendi, G., Comitato, A., Marigo, V., & Recchia, A. (2016) · Molecular Therapy — Nucleic Acids · doi:10.1038/mtna.2016.92 · Cited by 168
CRISPR/Cas9-induced shank3b mutant zebrafish display autism-like behaviors
Liu, C., Li, C., Hu, C.-C., Wang, Y., Lin, J., Jiang, Y., Li, Q., & Xu, X. (2018) · Molecular Autism · doi:10.1186/s13229-018-0204-x · Cited by 170
Engineering Human Stem Cell Lines with Inducible Gene Knockout using CRISPR/Cas9
Chen, Y., Cao, J., Xiong, M., Petersen, A. J., Dong, Y. W., Tao, Y., Huang, C. T.-L., Du, Z., & Zhang, S. (2015) · Cell stem cell · doi:10.1016/j.stem.2015.06.001 · Cited by 167
Jiang, W., Yang, B., & Weeks, D. P. (2014) · PLoS ONE · doi:10.1371/journal.pone.0099225 · Cited by 167
Huang, C.-H., Shen, C. R., Li, H., Sung, L.-Y., Wu, M.-Y., & Hu, Y.-C. (2016) · Microbial Cell Factories · doi:10.1186/s12934-016-0595-3 · Cited by 164
Metadata
- Authors
- Mali, P., Yang, L., Esvelt, K. M., Aach, J., Guell, M., DiCarlo, J. E., Norville, J. E., & Church, G. M.
- Affiliations
- Harvard University (US)
- Department of Genetics, Harvard Medical School, Boston, MA 02115, USA.
- Boston University (US)
- Corresponding author
- Mali, Prashant
- Yang, Luhan
- Church, George M.
- Venue
- Science
- Published
- 2013-02-15
- Volume
- 339
- Issue
- 6121
- Pages
- 823-826
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- PMC
- PMC3712628
- OpenAlex
- W2003171404
- Cited by
- 9,210
- References
- 46
- Citations by year
- 2026: 286 · 2025: 408 · 2024: 518 · 2023: 568 · 2022: 727 · 2021: 789 · 2020: 795 · 2019: 813 · 2018: 864 · 2017: 863 · 2016: 884 · 2015: 697 · 2014: 680 · 2013: 307
- FWCI
- 383.86
- Type
- journal article
- Language
- en
- Open access
- green
- europepmc.org
- Locations
- Science (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- RECERCAT (Consorci de Serveis Universitaris de Catalunya) (acceptedVersion)
- Repositori digital de la UPF (Universitat Pompeu Fabra) (submittedVersion)
- Funders
- National Human Genome Research Institute (P50HG005550)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › CRISPR and Genetic Engineering
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA regulation and disease
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA Interference and Gene Delivery
- Keywords
- CRISPR/Cas9, guide RNA, human genome editing, AAVS1, multiplex genome editing, induced pluripotent stem cells, K562 cells, HEK293T cells, RNA-guided nucleases
- MeSH terms
- Chromosomes, Human, Pair 19, Codon, Exons, Genetic Engineering, Humans, RNA, Genome, Human, Gene Targeting, K562 Cells, DNA Cleavage, Inverted Repeat Sequences, Genetic Loci, Induced Pluripotent Stem Cells, Clustered Regularly Interspaced Short Palindromic Repeats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
